Enrique
Raviña Rubira
Publicacións nas que colabora con Enrique Raviña Rubira (45)
2017
-
3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation
ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933
2014
-
Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands
European Journal of Medicinal Chemistry, Vol. 71, pp. 237-249
2011
-
Potential atypical antipsychotics: Synthesis, binding affinity and SAR of new heterocyclic bioisosteric butyrophenone analogues as multitarget ligands
MedChemComm, Vol. 2, Núm. 12, pp. 1194-1200
2009
-
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 21, pp. 6059-6062
-
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 6, pp. 1773-1778
2008
-
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 6, pp. 2852-2869
-
Corrigendum to "1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor" [Bioorg. Med. Chem. 16 (2008) 2852-2869] (DOI:10.1016/j.bmc.2008.01.002)
Bioorganic and Medicinal Chemistry
-
Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2′-furyl)-1,2,4-triazolo[1,5-a]quinoxalines
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 4, pp. 2103-2113
-
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics
Journal of Medicinal Chemistry, Vol. 51, Núm. 19, pp. 6085-6094
2007
-
Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity
Journal of Medicinal Chemistry, Vol. 50, Núm. 26, pp. 6476-6484
-
Multistructure 3D-QSAR studies on a series of conformationally constrained butyrophenones docked into a new homology model of the 5-HT2A receptor
Journal of Medicinal Chemistry, Vol. 50, Núm. 14, pp. 3242-3255
-
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics
Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 17, pp. 4873-4877
2006
-
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor
Journal of Medicinal Chemistry, Vol. 49, Núm. 1, pp. 282-299
-
Efficient consecutive alkylation-Knoevenagel functionalisations in formyl aza-heterocycles using supported organic bases
Synlett, pp. 3324-3328
-
Pyridazines part 41: Synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl) pyridazin-3(2H)-ones
Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 4, pp. 1080-1083
-
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine
Neuropharmacology, Vol. 51, Núm. 2, pp. 251-262
2005
-
Synthesis and binding affinity of novel 3-aminoethyl-1-tetralones, potential atypical antipsychotics
Bioorganic and Medicinal Chemistry Letters, Vol. 15, Núm. 12, pp. 3063-3066
2004
-
8-Substituted-9-deazaxanthines as adenosine receptor ligands: Design, synthesis and structure-affinity relationships at A 2B
European Journal of Medicinal Chemistry, Vol. 39, Núm. 10, pp. 879-887
-
Chemoenzymatic synthesis and binding affinity of novel (R)- and (S)-3-aminomethyl-1-tetralones, potential atypical antipsychotics
Bioorganic and Medicinal Chemistry Letters, Vol. 14, Núm. 3, pp. 585-589
-
Pyridazine derivatives. Part 38: Efficient Heck alkenylation at position 5 of the 6-phenyl-3(2H)-pyridazinone system
Tetrahedron Letters, Vol. 45, Núm. 17, pp. 3459-3463